Generic Companies with Tentative Approvals for: Chartwell Molecular
✉ Email this page to a colleague
Chartwell Molecular Generic Filers with Tentative Approvals
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Applicant | Generic Name | NDA | Strength | Dosage Form |
---|---|---|---|---|
Chartwell Molecular | bosentan | 210342 | 125MG | TABLET;ORAL |
Chartwell Molecular | sumatriptan succinate | 077696 | 50MG | TABLET; ORAL |
Chartwell Molecular | bosentan | 210342 | 62.5MG | TABLET;ORAL |
Chartwell Molecular | sumatriptan succinate | 077696 | 100MG | TABLET; ORAL |
>Applicant | >Generic Name | >NDA | >Strength | >Dosage Form |